Voxel-based Morphometry of Brain MRI in Normal Aging and Alzheimer's Disease

Hiroshi Matsuda1

  • 1Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, Tokyo, Japan.

Aging and Disease
|February 21, 2013
PubMed

Insights

Voxel-based morphometry (VBM) software aids Alzheimer's disease (AD) assessment by analyzing brain MRI scans. It detects age-related gray matter atrophy, crucial for early AD diagnosis and monitoring disease progression.

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Voxel-based morphometry (VBM) is a key technique for analyzing structural brain MRI in normal aging and Alzheimer's disease (AD).
  • VBM involves image segmentation, standardization, smoothing, and statistical analysis to quantify regional brain volume changes.
  • Common VBM techniques include optimized VBM using Statistical Parametric Mapping (SPM) and SPM8 with DARTEL (Diffeomorphic Anatomical Registration Exponentiated Lie Algebra).

Purpose of the Study:

  • To introduce novel VBM software for clinical assessment of Alzheimer's disease.
  • To provide a tool for comparing patient MRI data against a normative database.

Main Methods:

  • Utilized VBM with SPM8 and DARTEL for non-linear registration of brain MRI data.
  • Developed stand-alone software for Windows, integrating these VBM techniques.
  • Generated Z-score maps comparing individual patient scans to a database of healthy controls.

Main Results:

  • Normal aging is associated with gray matter atrophy in frontal and insular cortical regions.
  • Specific structures like the amygdala, hippocampus, and thalamus appear preserved in normal aging.
  • In Alzheimer's disease, VBM shows atrophy progression correlating with Braak's stages, beginning in medial temporal structures.

Conclusions:

  • The developed VBM software serves as an adjunct tool for the clinical evaluation of Alzheimer's disease.
  • This software facilitates the objective assessment of brain atrophy patterns relevant to AD progression.
  • The Z-score map output aids in identifying deviations from normal aging patterns, supporting AD diagnosis.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...